New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 20, 2012
17:16 EDTMNTAVisium Balanced Master Fund reports 7% passive stake in Momenta Pharma
News For MNTA From The Last 14 Days
Check below for free stories on MNTA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 15, 2014
10:36 EDTMNTAHigh option volume stocks
Subscribe for More Information
September 8, 2014
09:27 EDTMNTALeerink biotech analyst holds a luncheon meeting with a conference call
Biotech Analyst Schwartz provides an update on key trends and controversies for marketed MS therapies and discusses new data presented at ACTRIMS-ECTRIMS at a Luncheon Meeting with an Analyst/Industry conference call to be held in Boston on September 11 at 12:15 pm.
08:32 EDTMNTAMomenta Pharma exercises option to acquire antibody program from AnaptysBio
AnaptysBio announced that Momenta Pharma has exercised its option to acquire a novel antibody program from AnaptysBio. Upon payment of an option exercise fee to AnaptysBio, Momenta has received worldwide rights to therapeutic antibodies against a target selected based upon the anti-inflammatory effects of IVIg. The aforementioned option right was granted by AnaptysBio to Momenta under an agreement signed between the companies in December 2013.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use